Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.
Latest
20:15 ET Global Clinical Trial Supply and Logistics Market for Pharma 2017-2027
Report Details The Global Clinical Trial Supply and Logistics Market is expected to grow at a CAGR of 7.0% from 2016-2021 and CAGR of 5.6% from...
16:00 ET Second Phase 3 Study Shows KYPROLIS® (Carfilzomib) Regimen Significantly Improves Overall Survival In Patients With Relapsed Multiple Myeloma
Amgen (NASDAQ:AMGN) today announced positive results from the final analysis of the Phase 3 ASPIRE trial. The study met the key secondary endpoint...
12:45 ET The Feinstein Institute and Applied Immunotherapeutics, Inc. Agree to Develop New Anti-Inflammatory Treatments for Autoimmune Disease
The Feinstein Institute for Medical Research at Northwell Health announced that it has agreed to license the rights to breakthrough discoveries in...
10:25 ET The GARFIELD-VTE Registry's First-ever Results Presented at the ISTH 2017 Congress Shed Light on a Wide Heterogeneity of VTE Patients Across the Globe, their Treatment and Outcomes
- With uniquely broad inclusion criteria, the registry covers diverse populations of patients with VTE across a range of clinical...
10:00 ET New Study Finds No Additional Benefit from (RS) Meso-Zeaxanthin
A study by co-author John Nolan, PhD, of the Macular Pigment Research Group at Waterford Institute of Technology and presented at the 18th...
09:00 ET New Data Demonstrate Prophylactic Treatment with IDELVION® Reduces Bleed Frequency and Has Potential to Positively Impact Patients with Haemophilia B
CSL Behring today presented data finding that prophylaxis treatment with IDELVION® provides consistently high factor IX levels, resulting in low...
09:00 ET Eli Lilly and Company to Present More Than 40 Abstracts at the Alzheimer's Association International Conference® 2017 (AAIC® 2017)
Data highlights include important health outcomes data emphasizing the need for timely detection and management of Alzheimer's disease Eli...
09:00 ET New Research Finds EarlySense's Contact-Free Sensor Accurately Detects Sleep Apnea and Disordered Breathing in Children
EarlySense, the market leader in contact-free continuous monitoring solutions, announced today new research indicating that its EarlySense Live™...
09:00 ET Astrocytic Gene in the Brain Determines the Language Learning Ability of Humans
- Collaboration of KIST-Ewha Womans University identified that the astrocytic gene affect changes in brain size and cognitive function. - The...
08:30 ET QR Pharma, Inc. Presents New Data on Posiphen in Down Syndrome at the Alzheimer's Disease International Conference (AAIC 2017 London)
QR Pharma, Inc., a privately held phase 2 biopharmaceutical company developing novel therapies for the treatment of Alzheimer's (AD), Parkinson's...
08:30 ET PLAYING IT SAFE: In Quest to Improve Patient Outcomes Hospitals Use Biomarkers to Gauge Patient Risk for Acute Kidney Injury
For critically ill hospital patients, no matter what the primary health problem, one of the most serious and frequent complications clinicians...
08:15 ET Bio Products Laboratory Presents New Phase 3 Data Demonstrating Prophylactic Coagadex® (Coagulation Factor X, Human) Dosing Prevents or Reduces Bleeding Episodes in Children with Moderate to Severe Hereditary Factor X Deficiency
Bio Products Laboratory Limited (BPL), a leading manufacturer of plasma-derived protein therapies, presented this week new data from TEN02, the...
08:00 ET Regen BioPharma, Inc. Researchers Discover New Dynamic Compound Which Modulates the NR2F6 Checkpoint
Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP), today reported continued progress in developing small molecule drugs that activate and...
08:00 ET Neuraltus Announces Completion of Enrollment in Confirmatory Phase 2 Study of NP001 in ALS Patients with Systemic Inflammation
Neuraltus Pharmaceuticals, Inc., a privately-held biopharmaceutical company dedicated to developing innovative therapeutics for...
07:30 ET Le moustique Friendly™ Aedes d'Oxitec reçoit une évaluation positive pour la norme européenne en matière de santé humaine et d'environnement
Le RIVM conclut à un risque négligeable concernant les moustiques Friendly™ Aedes d'Oxitec Le Haut Conseil des biotechnologies en France...
07:00 ET Viking Therapeutics Completes Enrollment in Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...
07:00 ET Asterias Biotherapeutics Completes Enrollment and Dosing of SCiStar Study's AIS-B 10 Million Cell Cohort
Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company pioneering the field of regenerative medicine, today announced completion...
06:46 ET Эксалиеф® (эсликарбазепин) не оказывает существенного негативного влияния на нейрокогнитивные функции у детей с фокальной эпилепсией согласно результатам исследования
ТОЛЬКО ДЛЯ СМИ ЕВРОПЫ, БЛИЖНЕГО ВОСТОКА И АФРИКИ - НЕ ПРЕДНАЗНАЧЕНО ДЛЯ ЖУРНАЛИСТОВ ИЗ ШВЕЙЦАРИИ/АВСТРИИ - Эсликарбазепин не оказывает...
Jul 11, 2017, 14:01 ET Missouri is the First State to Institute Newborn Screening for Spinal Muscular Atrophy
Governor Eric Greitens today signed into law Senate Bill 50, instituting newborn screening for spinal muscular atrophy (SMA). The bill will make...
Jul 11, 2017, 12:44 ET Removing Blue from LED Light at Night May Reduce Obesity and Diabetes Risk
The harmful effects of conventional LED lights at night, which disrupt circadian clocks and increase appetite, insulin resistance and diabetes...
Jul 11, 2017, 11:15 ET Autism Center at Rush Seeking Participants for Social Skills Study
Chicagoland families and providers with children on the autism spectrum are invited to enroll in a groundbreaking social skills study. The Autism...
Jul 11, 2017, 10:22 ET New Prospective, Randomized Controlled Study Compares The Safety And Performance Of A Next Generation Adipose Tissue Technology (Lipogems®) Vs. Platelet Rich Plasma In Patients With Knee Osteoarthritis
"Lipogems has been used in over 20,000 cases worldwide in a variety of clinical settings, including studies that have evaluated its use in...
Jul 11, 2017, 10:00 ET Morphotek Announces Publication Uncovering One Of The Mechanisms By Which The Tumor-Produced CA125 Protein Suppresses Immune-Mediated Killing Via Farletuzumab
Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that a publication entitled "Tumor antigen CA125 suppresses antibody-dependent...
Jul 11, 2017, 09:00 ET ViraCyte Completes Phase 1 Clinical Trial of Viralym-C
ViraCyte, LLC, a clinical stage biopharmaceutical company developing cellular immunotherapies for severe infections, today announced the successful...
Jul 11, 2017, 08:50 ET Oramed Announces End-of-Phase 2 Meeting with FDA to Initiate Phase 3 Program
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...
Most Viewed
Jul 10, 2017, 16:01 ET Arena Pharmaceuticals Reports Positive Topline Phase 2 Results for Ralinepag in Patients with Pulmonary Arterial Hypertension
Jul 06, 2017, 11:15 ET Regenerating Knee Cartilage with Stem Cells: Groundbreaking Clinical Trial Underway at Andrews Institute
Jul 10, 2017, 06:45 ET FDA Grants Priority Review for Lilly's Abemaciclib for the Treatment of Advanced Breast Cancer
Jul 11, 2017, 03:30 ET BioMarin's Investigational Gene Therapy for Hemophilia A at 6e13 vg/kg Dose Maintains Average Factor VIII Levels within Normal Range for over One Year
Jul 10, 2017, 07:00 ET New Data Presented at Peripheral Nerve Society Meeting Further Support Potential Benefit of Inotersen
